Pharmacovigilance Market Dynamics and Service Provider Benchmarking

Report Overview

Data collected by ISR suggest that a large portion of pharmacovigilance activity is and will continue to be outsourced to CROs, niche providers, and business process optimization companies.

The information in this report is valuable to sponsors as a means of making more informed outsourcing decisions, and it provides vendors with data regarding what sponsors are looking for in terms of pharmacovigilance service offerings and capabilities.

What you will learn:

• Phases and types of pharmacovigilance activities outsourced by sponsors
• How case processing, regulatory reporting, and benefit-risk management spending is distributed across in-house resources, larger CROs, mid-size CROs, niche pharmacovigilance providers, and business process optimization companies (BPOs)
• The attributes sponsors value most in a pharmacovigilance vendor, the use of preferred providers, and the familiarity with specific vendor offerings
• Future projections for many of these metrics such as the current percent of companies using preferred providers and the anticipated percent of companies using preferred providers in 2016
• Satisfaction with providers and user experience feedback across 12 different attributes for 41 individual pharmacovigilance service providers
• Which drug safety databases are being used most often, which rank highest in user experience, and which attributes are most important when sponsors select a database
• What changes sponsors expect in the pharmacovigilance space (specifically regarding the utilization of social media and automation tools) and how their respective companies plan to adapt to these changes

Report Contents:

1. Executive Summary
2. Use of Pharmacovigilance Services
3. Trends in Spending
4. Outsourcing Behavior and Experience
5. Provider-Specific Attribute Performance
6. Drug Safety Database Experience
7. Database-Specific Attribute Performance
8. Adaptation to Change
9. Demographics and Responsibilities